Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
OBSERVATIONAL
2021-11-18
2025-10-14
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The investigators will test 5-10 subjects with existing sacral anterior root stimulation (SARS) devices and look at the effects of high frequency (up to 600Hz) compared to the usual low frequency stimulation on bladder function. The investigators are particularly interested in whether it is possible to reproduce a 'functional' dorzal rhizotomy using high frequency stimulation of the S2 efferent nerves
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
High Frequency SARS for Neurogenic Bladder and Bowel Emptying
NCT05214378
Chronic Electrical Stimulation to Reduce Bladder Hyperreflexia
NCT03472599
Transcutaneous Spinal Cord Stimulation With Bladder and Pelvic Floor Muscle Training
NCT05504200
Sacral Nerve Stimulation in Improving Bladder Function After Acute Traumatic Spinal Cord Injury
NCT03083366
Effects of Sacral and Tibial Stimulation on Bladder Function in Subacute Suprasacral Spinal Cord Injury
NCT07343583
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Participants will be patients with clinically complete spinal cord injury who already have a commercially available implanted Finetech Brindley bladder stimulator with electrodes on the sacral nerves or roots, controlled by an external transmitter whose frequency can be adjusted by the investigator. This study will explore modified stimulation parameters and will deliver the stimulation pattern with a modified/experimental external stimulation control unit. The motivation for exploring these parameters is to see if clinical efficacy might be improved for future systems.
Primary outcome: Measurement of the effects of high and low frequency stimulation of the sacral efferent nerves on Bladder Pressure, rectal pressure, Detrusor pressure, Sphincter pressure, volume voided, post-void residual volume, voiding flow rate
Secondary measures: Effects of low frequency stimulation on bladder pressure, bladder capacity and reflex incontinence
The exploration of these novel stimulation parameters will require modification of the existing CE-marked system. The modifications will be limited to the external stimulation control unit, and will not compromise either the implantable system or its capability to continue normal operation with the existing CE-marked external control unit. The modified external stimulation control unit will be referred to as the "research stimulation controller." The use environment for the research stimulation controller will be a controlled hospital/laboratory setting, under clinical supervision. Outside of the clinic, the CE-marked system will be used to ensure normal therapy is provided to the subject. Access to the research stimulation controller will be controlled by the PI to prevent inadvertent misuse.
The development of the research stimulation controller will follow accepted good design practices. More specifically, the team will use a scaled version of 13845-compliant processes to 1) assess user needs 2) generate a risk analysis and plan 3) develop system requirements from design inputs 4) document and summarize design outputs 5) perform device verification tests and 6) perform user validation tests. These files will be maintained in a controlled document system.
The modified controller is similar to the CE marked device but will allow the investigators to explore a wider range of electrical stimulation parameters such as different waveforms and higher frequencies. Our intention is to use up to 600 Hz frequencies, compared to the existing frequencies in this device of up to 53 Hz. These changes are modest and are well within the energy delivery provided by existing commercial neuromodulation systems such as spinal cord stimulation (typical parameters for spinal cord stimulation include the Nevro® system that delivers up to 10kHz). Patients both with and without posterior sacral rhizotomy will also be included. No further surgery is required. Measurements of bladder function will be made in the urodynamic laboratory.
The study is prospective and unblinded. Each participant will serve as their own control; outcome measures will be compared with different frequencies of electrical stimuli and with no electrical stimuli.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Sacral Anterior Root Stimulation (SARS)
Comparison of High frequency versus low frequency stimulation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Male or female, aged 18 years or over.
* Patients willing and able to give informed consent to involvement in the study
Exclusion Criteria
* Patients are taking part in any studies on drugs or devices that alter bladder or autonomic function
* Any other significant comorbidity or illness that would preclude their participation or increase the risk to them of participating in the study
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Oxford
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Oxford
Oxford, Oxon, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRAS 260021
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.